Lv0
0 积分 2026-10-08 加入
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial
11小时前
已完结
Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial
12小时前
已完结
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
13小时前
已完结
皖公网安备34019202002308
